BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 36709858)

  • 1. Mechanisms of pulmonary microvascular endothelial cells barrier dysfunction induced by LPS: The roles of ceramides and the Txnip/NLRP3 inflammasome.
    Ouyang H; Wang Y; Wu J; Ji Y
    Microvasc Res; 2023 May; 147():104491. PubMed ID: 36709858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPS induces pulmonary microvascular endothelial cell barrier dysfunction by upregulating ceramide production.
    Jiang J; Ouyang H; Zhou Q; Tang S; Fang P; Xie G; Yang J; Sun G
    Cell Signal; 2022 Apr; 92():110250. PubMed ID: 35065241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ASM/Cer/TXNIP signaling module in the NLRP3 inflammasome activation.
    Jiang J; Shi Y; Cao J; Lu Y; Sun G; Yang J
    Lipids Health Dis; 2021 Feb; 20(1):19. PubMed ID: 33612104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NALP-3 inflammasome silencing attenuates ceramide-induced transepithelial permeability.
    Kolliputi N; Galam L; Parthasarathy PT; Tipparaju SM; Lockey RF
    J Cell Physiol; 2012 Sep; 227(9):3310-6. PubMed ID: 22169929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
    Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
    Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of long non-coding RNA MEG3 alleviates lipopolysaccharide-induced acute lung injury by acting as a molecular sponge of microRNA-7b to modulate NLRP3.
    Liao H; Zhang S; Qiao J
    Aging (Albany NY); 2020 Aug; 12(20):20198-20211. PubMed ID: 32852284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
    Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CaMK4 Promotes Acute Lung Injury Through NLRP3 Inflammasome Activation in Type II Alveolar Epithelial Cell.
    Zhang T; Li M; Zhao S; Zhou M; Liao H; Wu H; Mo X; Wang H; Guo C; Zhang H; Yang N; Huang Y
    Front Immunol; 2022; 13():890710. PubMed ID: 35734175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
    Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M
    Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for Advanced Glycation End-Products Promotes Activation of Alveolar Macrophages through the NLRP3 Inflammasome/TXNIP Axis in Acute Lung Injury.
    Lenga Ma Bonda W; Fournet M; Zhai R; Lutz J; Blondonnet R; Bourgne C; Leclaire C; Saint-Béat C; Theilliere C; Belville C; Bouvier D; Blanchon L; Berger M; Sapin V; Jabaudon M
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
    Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
    Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury
    Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H
    Front Immunol; 2022; 13():846384. PubMed ID: 35281058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLRP3 gene silencing ameliorates phosgene-induced acute lung injury in rats by inhibiting NLRP3 inflammasome and proinflammatory factors, but not anti-inflammatory factors.
    He DK; Xu N; Shao YR; Shen J
    J Toxicol Sci; 2020; 45(10):625-637. PubMed ID: 33012731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
    Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX
    Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total tanshinones protect against acute lung injury through the PLCγ2/NLRP3 inflammasome signaling pathway.
    Li X; Qiu H; Gan J; Liu Z; Yang S; Yuan R; Gao H
    J Ethnopharmacol; 2023 Oct; 314():116478. PubMed ID: 37121449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xuanbai Chengqi Decoction alleviates acute lung injury by inhibiting NLRP3 inflammasome.
    Wang S; Lin F; Zhang C; Gao D; Qi Z; Wu S; Wang W; Li X; Pan L; Xu Y; Tan B; Yang A
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117227. PubMed ID: 37751794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Gingerol attenuates sepsis-induced acute lung injury by suppressing NLRP3 inflammasome through Nrf2 activation.
    Pan Q; Liu P; Wan M
    Folia Histochem Cytobiol; 2023; 61(1):68-80. PubMed ID: 36734635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YuPingFengSan ameliorates LPS-induced acute lung injury and gut barrier dysfunction in mice.
    Wang Y; Wang Y; Ma J; Li Y; Cao L; Zhu T; Hu H; Liu H
    J Ethnopharmacol; 2023 Aug; 312():116452. PubMed ID: 37019161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective effect of heat shock transcription factor 1 on acute lung injury in septic rats by regulating NOD-like receptor protein 3 inflammasome activation].
    Jin C; Zhang W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1167-1172. PubMed ID: 36567560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
    Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
    J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.